Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Florfenicol
Livisto Int'l S.L.
QJ01BA90
Florfenicol
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Pigs, Sheep
Antimicrobial
Authorized
2017-05-16
Revised: July 2023 AN: 00480/2023 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERSTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cadorex 300 mg/ml solution for injection for cattle, sheep and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Florfenicol 300 mg EXCIPIENTS: N-methyl pyrrolidone 250 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, light yellow to straw-coloured, somewhat viscous solution, free from foreign matter. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, sheep and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: Diseases caused by florfenicol susceptible bacteria: Treatment of respiratory tract infections in cattle due to _Mannheimia haemolytica, Pasteurella multocida _ and_ Histophilus somni. _ Sheep: Treatment of ovine respiratory tract infections due to _Mannheimia haemolytica _ and _Pasteurella multocida_. Pigs: Treatment of acute outbreaks of swine respiratory disease caused by strains of _Actinobacillus pleuropneumoniae_ and _Pasteurella multocida_. 4.3 CONTRAINDICATIONS Do not use in adult bulls and rams intended for breeding purposes. Do not administer to boars intended for breeding. Revised: July 2023 AN: 00480/2023 Page 2 of 8 Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals This medicinal product does not contain any antimicrobial preservative. The safety of the product has not been established in sheep under 7 weeks of age. Do not use in piglets of less than 2 kg. Use of the product should be based on identification and susceptibility testing of the target pathogens. Use of the product should be in accordance with official, national and regional antimicrobial policies. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the florfenicol and m Read the complete document